Impact of alemtuzumab dosing and low-dose total body irradiation on cytomegalovirus infection in allogeneic hematopoietic stem cell transplantation
Leuk Lymphoma
.
2020 Dec;61(12):3024-3026.
doi: 10.1080/10428194.2020.1791855.
Epub 2020 Jul 11.
Authors
Maxwell Brown
1
,
Rza Abasov
1
,
David Salerno
1
,
Tsiporah B Shore
2
,
Usama Gergis
2
,
Sebastian Mayer
2
,
Adrienne Phillips
2
,
Jingmei Hsu
2
,
Rosy Priya L Kodiyanplakkal
3
,
Michelle Pasciolla
1
,
Koen van Besien
2
Affiliations
1
Department of Pharmacy, NewYork-Presbyterian/Weill Cornell Medical Center.
2
Division of Hematology and Oncology, Department of Medicine, NewYork-Presbyterian, Weill Cornell Medical Center.
3
Division of Infectious Diseases, Department of Medicine, NewYork-Presbyterian, Weill Cornell Medical Center.
PMID:
32654572
DOI:
10.1080/10428194.2020.1791855
No abstract available
Publication types
Letter
MeSH terms
Alemtuzumab / adverse effects
Cytomegalovirus Infections*
Graft vs Host Disease*
Hematopoietic Stem Cell Transplantation* / adverse effects
Humans
Transplantation Conditioning / adverse effects
Whole-Body Irradiation
Substances
Alemtuzumab